- Home
- ARTW vs PPBT Comparison
ARTW vs PPBT Comparison
Compare ARTW & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- PPBT
- Stock Information
- Founded
- ARTW 1956
- PPBT 2010
- Country
- ARTW United States
- PPBT Israel
- Employees
- ARTW N/A
- PPBT N/A
- Industry
- ARTW Industrial Machinery/Components
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- ARTW Industrials
- PPBT Health Care
- Exchange
- ARTW Nasdaq
- PPBT Nasdaq
- Market Cap
- ARTW 9.3M
- PPBT 6.2M
- IPO Year
- ARTW N/A
- PPBT N/A
- Fundamental
- Price
- ARTW $2.17
- PPBT $2.53
- Analyst Decision
- ARTW
- PPBT Strong Buy
- Analyst Count
- ARTW 0
- PPBT 1
- Target Price
- ARTW N/A
- PPBT $33.00
- AVG Volume (30 Days)
- ARTW 37.3K
- PPBT 18.2K
- Earning Date
- ARTW 07-10-2025
- PPBT 08-15-2025
- Dividend Yield
- ARTW N/A
- PPBT N/A
- EPS Growth
- ARTW N/A
- PPBT N/A
- EPS
- ARTW 0.14
- PPBT N/A
- Revenue
- ARTW $23,916,932.00
- PPBT N/A
- Revenue This Year
- ARTW N/A
- PPBT N/A
- Revenue Next Year
- ARTW N/A
- PPBT N/A
- P/E Ratio
- ARTW $41.46
- PPBT N/A
- Revenue Growth
- ARTW N/A
- PPBT N/A
- 52 Week Low
- ARTW $1.40
- PPBT $2.00
- 52 Week High
- ARTW $4.15
- PPBT $13.95
- Technical
- Relative Strength Index (RSI)
- ARTW 56.83
- PPBT 56.04
- Support Level
- ARTW $2.04
- PPBT $2.35
- Resistance Level
- ARTW $2.44
- PPBT $2.58
- Average True Range (ATR)
- ARTW 0.15
- PPBT 0.12
- MACD
- ARTW -0.01
- PPBT 0.02
- Stochastic Oscillator
- ARTW 57.03
- PPBT 84.38
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.